Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner
Josephe A. Honorat(Osaka University), Tatsusada Okuno(The University of Osaka), Akiko Namba(The University of Osaka), Kazushiro Takata(Osaka Prefectural Medical Center), Hideki Mochizuki(Osaka Gakuin University), Hisae Sumi‐Akamaru(The University of Osaka), Mikito Shimizu(Shimizu (Japan)), Makoto Kinoshita(Institute for Atherosclerosis Research), Tsutomu Sasaki(The University of Osaka), Manabu Sakaguchi(Osaka Prefectural Medical Center), Kazuya Yamashita(Keio University), Saburo Sakoda(Toyonaka Municipal Hospital), Takashi Shirakura(Teijin (Japan)), Yuji Nakatsuji(University of Toyama), Toru Koda(The University of Osaka), Eri Sanda(The University of Osaka), Mizuho Tamura(Teijin (Japan)), Atsushi Kumanogoh(The University of Osaka)
Cited by 22
Related Papers
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k
Glial fibrillary acidic protein immunoglobulin <scp>G</scp> as biomarker of autoimmune astrocytopathy: Analysis of 102 patients
|Annals of Neurology|2017|542
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version
|Journal of Atherosclerosis and Thrombosis|2013|469